Tag: FDA
Amneal & Impax merger to create 5th biggest pharma generics firm...
Combined company to benefit from expanded generics product portfolio, premier diversified generics pipeline, broad R&D capabilities across dosage forms, high-quality and low-cost global manufacturing and distribution network, and enhanced financial foundation........
Aplagon partners with Cadila to develop & test antithrombotic products in...
Aplagon has partnered with Cadila Pharmaceuticals to develop and commercialize APAC First-in-Class antithrombotics for the prevention of blood vessel occlusions related to vascular interventions..........
Pharma recalls posing a serious threat?
There have been several other instances wherein drugs are being recalled either on a firm's own initiative or the request by Food and Drug Administration (FDA)............
MTaI welcomes government’s move to establish MedTech Assessment Board
The MTAB (Medical Technology Assessment Board) is expected to optimize clinical effectiveness, cost effectiveness, and safety, social, ethical, and legal applications of healthcare interventions.......
GNH India clears audit to trade ‘Orphan Drugs’ with UK
With this new development, GNH India becomes one more pharma wholesaler among few to have forayed into the United Kingdom market as a legal distributor of rare and life-saving drugs..........
Dr Reddy’s Laboratories gets USFDA’s EIR to API plant in Telangana
The US Food and Drug Administration has given an 'establishment inspection report' to the company after inspection of Dr Reddy Laboratories active pharmaceutical ingredients (API) unit at Miryalaguda in Telangana.........
USFDA to lift import alert on Sun Pharma’s Mohali facility
Regulator will permit the supply of products from Mohali facility inherited by Sun Pharma from Ranbaxy, to the US market .........
Biotech companies join the ‘Make in India’ bandwagon
The promising biotechnology sector has joined the India centric manufacturing campaign in their own way if one goes....
FDA Advisory Committee recommends approval of Sanofi’s Type 2 Diabetes cure
FDA decisions on the investigational fixed-ratio combination of basal insulin glargine is expected in third quarter of 2016...
Biotech patents decline globally, crucial times ahead: Thomson Reuters Study
Now in its seventh year, the annual study analyzes global intellectual property data...